Intracellular delivery of targeted lipid nanoparticles across three resistant tumour models
DOI pending registration · Drug Delivery
Selected for the inaugural issue as a clear example of the reporting standard the journal expects: complete formulation detail, prespecified endpoints and openly stated limitations.
